Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Heritage Insurance And 3 Other Stocks Under $4 Insiders Are Aggressively Buying

Published 21/03/2023, 13:10
© Reuters.  Heritage Insurance And 3 Other Stocks Under $4 Insiders Are Aggressively Buying

Benzinga - The Dow Jones closed higher by more than 1% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

PHX Minerals

  • The Trade: PHX Minerals Inc. (NYSE: PHX) 10% owner Jonathan Brolin acquired a total of 5,451 shares an average price of $2.38. To acquire these shares, it cost around $12.97 thousand.
  • What’s Happening: PHX Minerals posted downbeat Q1 earnings.
  • What PHX Minerals Does: PHX Minerals, previously Panhandle Oil & Gas, is an oil and natural gas mineral company that has employed a strategy to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership.
Heritage Insurance Holdings
  • The Trade: Heritage Insurance Holdings, Inc. (NYSE: HRTG) CEO Ernie J Garateix acquired a total 2,000 shares at an average price of $3.11. The insider spent around $6.22 thousand to buy those shares.
  • What’s Happening: Heritage Insurance reported better-than-expected Q4 sales results.
  • What Heritage Insurance Does: Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products.

IO Biotech

  • The Trade: IO Biotech, Inc. (NASDAQ: IOBT) CFO Amy Sullivan acquired a total of 25,000 shares at an average price of $2.32. To acquire these shares, it cost around $58.02 thousand.
  • What’s Happening: IO Biotech posted a wider-than-expected quarterly loss.
  • What IO Biotech Does: IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Bird Global

  • The Trade: Bird Global, Inc. (NYSE: BRDS) CEO Shane Torchiana acquired a total of 200,000 shares at an average price of $0.13. The insider spent $26 thousand to buy those shares.
  • What’s Happening: Bird Global reported better-than-expected Q4 sales results.
  • What Bird Global Does: Bird Global Inc is a micro-mobility company engaged in delivering electric transportation solutions for short distances.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.